RU2018121234A - Схема лечения плазминогеном для заживления раны - Google Patents

Схема лечения плазминогеном для заживления раны Download PDF

Info

Publication number
RU2018121234A
RU2018121234A RU2018121234A RU2018121234A RU2018121234A RU 2018121234 A RU2018121234 A RU 2018121234A RU 2018121234 A RU2018121234 A RU 2018121234A RU 2018121234 A RU2018121234 A RU 2018121234A RU 2018121234 A RU2018121234 A RU 2018121234A
Authority
RU
Russia
Prior art keywords
wound
approximately
dose
plasminogen
biologically active
Prior art date
Application number
RU2018121234A
Other languages
English (en)
Russian (ru)
Other versions
RU2018121234A3 (cg-RX-API-DMAC7.html
Inventor
Ульф БЕРТХЕЙМ
Тор Ню
Пьер Лорин
Мартин РОБИТАЙЛ
Original Assignee
Прометик Байотерепьютикс, Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Прометик Байотерепьютикс, Лтд. filed Critical Прометик Байотерепьютикс, Лтд.
Publication of RU2018121234A publication Critical patent/RU2018121234A/ru
Publication of RU2018121234A3 publication Critical patent/RU2018121234A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
RU2018121234A 2015-11-10 2016-11-10 Схема лечения плазминогеном для заживления раны RU2018121234A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562253352P 2015-11-10 2015-11-10
US62/253,352 2015-11-10
PCT/IB2016/001606 WO2017081529A1 (en) 2015-11-10 2016-11-10 Plasminogen dosage regimen for wound healing

Publications (2)

Publication Number Publication Date
RU2018121234A true RU2018121234A (ru) 2019-12-13
RU2018121234A3 RU2018121234A3 (cg-RX-API-DMAC7.html) 2020-03-12

Family

ID=57485826

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018121234A RU2018121234A (ru) 2015-11-10 2016-11-10 Схема лечения плазминогеном для заживления раны

Country Status (14)

Country Link
US (1) US20180326023A1 (cg-RX-API-DMAC7.html)
EP (1) EP3373957A1 (cg-RX-API-DMAC7.html)
JP (1) JP2018534306A (cg-RX-API-DMAC7.html)
KR (1) KR20180070708A (cg-RX-API-DMAC7.html)
CN (1) CN108289934A (cg-RX-API-DMAC7.html)
AU (1) AU2016352183A1 (cg-RX-API-DMAC7.html)
BR (1) BR112018009476A8 (cg-RX-API-DMAC7.html)
CA (1) CA3004509A1 (cg-RX-API-DMAC7.html)
IL (1) IL259172A (cg-RX-API-DMAC7.html)
MX (1) MX2018005876A (cg-RX-API-DMAC7.html)
RU (1) RU2018121234A (cg-RX-API-DMAC7.html)
TW (1) TW201722464A (cg-RX-API-DMAC7.html)
WO (1) WO2017081529A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201803010B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI868051B (zh) * 2017-06-23 2025-01-01 美商波麥堤克生物治療股份有限公司 與pai-1過表現相關之病狀的纖維蛋白溶酶原治療
CN111432762B (zh) * 2017-12-15 2023-01-13 墨尼克医疗用品有限公司 预防性敷料
BR112020003022A2 (pt) 2017-12-26 2020-08-25 Hirotaro Fukuoka composição farmacêutica para o uso no crescimento de cabelo, modificação do couro cabeludo ou pele, cicatrização de uma ferida, promoção da osteogênese ou modificação do cabelo
JP7682567B2 (ja) * 2020-11-17 2025-05-26 泰▲倫▼基国▲際▼有限公司 Ngfレベルを増加させる方法及び薬剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067492B2 (en) * 2001-09-06 2006-06-27 Omnio Ab Method of promoting healing of a tympanic membrane perforation
GB0509438D0 (en) 2005-05-09 2005-06-15 Prometic Biosciences Ltd Affinity adsorbets for fibrinogen
EP2249863A4 (en) * 2008-01-22 2011-12-28 Omnio Healer Ab METHOD OF ENHANCING WOUND HEALING
CA2823491A1 (en) 2011-01-05 2012-07-12 Thrombogenics Nv Plasminogen and plasmin variants
CA2844644A1 (en) 2011-08-12 2013-02-21 Thrombogenics N.V. Plasminogen and plasmin variants
PY1577621A (es) * 2014-12-19 2017-10-02 Prometic Biotherapeutics Inc Composicion farmaceutica que comprende plasminogeno y uso para el mismo
TWI801331B (zh) * 2015-11-03 2023-05-11 美商波麥堤克生物治療股份有限公司 纖維蛋白溶酶原缺乏症之纖維蛋白溶酶原替代療法

Also Published As

Publication number Publication date
WO2017081529A1 (en) 2017-05-18
MX2018005876A (es) 2018-11-09
EP3373957A1 (en) 2018-09-19
RU2018121234A3 (cg-RX-API-DMAC7.html) 2020-03-12
AU2016352183A1 (en) 2018-06-28
TW201722464A (zh) 2017-07-01
CN108289934A (zh) 2018-07-17
KR20180070708A (ko) 2018-06-26
US20180326023A1 (en) 2018-11-15
ZA201803010B (en) 2019-07-31
IL259172A (en) 2018-06-28
JP2018534306A (ja) 2018-11-22
BR112018009476A8 (pt) 2019-02-26
CA3004509A1 (en) 2017-05-18
BR112018009476A2 (pt) 2018-11-13

Similar Documents

Publication Publication Date Title
Oliveira et al. Therapeutic advances in wound healing
CY1113253T1 (el) Δοσολογικο σχημα για τη θεραπευτικη αντιμετωπιση μιας τραυματικης εγκεφαλικης βλαβης με προγεστερονη
JP2020530857A5 (cg-RX-API-DMAC7.html)
JP2014530873A5 (cg-RX-API-DMAC7.html)
RU2013154702A (ru) Заживление тканей
JP2013155188A5 (cg-RX-API-DMAC7.html)
CN105431175A (zh) 透皮递送系统
RU2016114098A (ru) Новое производное аналога инсулина
JP2017501154A5 (cg-RX-API-DMAC7.html)
JP2018534306A5 (cg-RX-API-DMAC7.html)
MX2015014939A (es) Nuevo uso de clorhidrato de landiolol en el tratamiento a largo plazo de taquiarritmias e hipertension.
RU2020140694A (ru) Способ лечения гипергликемии
JP2017537163A5 (cg-RX-API-DMAC7.html)
MX2018005876A (es) Regimen de dosificacion de plasminogeno para la cicatrizacion de heridas.
KR20120056322A (ko) 자나미비르를 유효성분으로 하는 경피제
CN104174009A (zh) 一种蝇蛆蛋白制剂及用途
Nagy et al. Negative pressure wound therapy: an effective, minimally invasive therapeutic modality in burn wound management
Karatieieva et al. Treatment of pyoinflammatory complications with individually selected ozone dose in patients with diabetes
EA201590825A1 (ru) Способы контролирования кровяного давления и снижения диспноэ при сердечной недостаточности
RU2008106606A (ru) Марля, пропитанная лекарственным средством
RU2013138852A (ru) Способ лечения нейропатических трофических язв при синдроме диабетической стопы
Glat et al. The use of Suprathel® in the treatment of pediatric burns: Retrospective review of first pilot trial in a burn unit in the United States
CN101837068B (zh) 椒目仁油喷雾剂的制备工艺和应用
RU2015134772A (ru) Применение биматопроста для повышения выработки лептина
CN105167913A (zh) 一种医疗敷药装置

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20200922